HuGE Literature Finder
Records
1
-
10
| HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1). Cancer science 2021 Oct . Ri Masaki, Iida Shinsuke, Maruyama Dai, Sakabe Aya, Kamei Ryo, Nakashima Takuto, Tohkin Masahiro, Osaga Satoshi, Tobinai Kensei, Fukuhara Noriko, Miyazaki Kana, Tsukamoto Norifumi, Tsujimura Hideki, Yoshimitsu Makoto, Miyamoto Kenichi, Tsukasaki Kunihiro, Nagai Hiroka |
| Killer cell immunoglobulin-like receptors in Thai patients with multiple myeloma. Asian Pacific journal of allergy and immunology 2021 Jan . Theeranawakam Aphiradee, Vejbaesya Sasijit, Khuhapinant Archrob, Sae-Tam Pradermch |
| The association of HLA-C alleles with multiple myeloma in Chinese patients. Experimental hematology & oncology 2018 7 19. Wang Xiaojing, An Gang, Wang Jiying, Zhang Yan, Li Qinghua, Wei Hui, Qiu Lugui, Ru K |
Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci.
Scientific reports 2017 Jan 7 41071. Law Philip J, Sud Amit, Mitchell Jonathan S, Henrion Marc, Orlando Giulia, Lenive Oleg, Broderick Peter, Speedy Helen E, Johnson David C, Kaiser Martin, Weinhold Niels, Cooke Rosie, Sunter Nicola J, Jackson Graham H, Summerfield Geoffrey, Harris Robert J, Pettitt Andrew R, Allsup David J, Carmichael Jonathan, Bailey James R, Pratt Guy, Rahman Thahira, Pepper Chris, Fegan Chris, von Strandmann Elke Pogge, Engert Andreas, Försti Asta, Chen Bowang, Filho Miguel Inacio da Silva, Thomsen Hauke, Hoffmann Per, Noethen Markus M, Eisele Lewin, Jöckel Karl-Heinz, Allan James M, Swerdlow Anthony J, Goldschmidt Hartmut, Catovsky Daniel, Morgan Gareth J, Hemminki Kari, Houlston Richard |
| NCOA1 is a novel susceptibility gene for multiple myeloma in the Chinese population: A case-control study. PloS one 2017 12 (3): e0173298. Peng Mengle, Zhao Guanfei, Yang Funing, Cheng Guixue, Huang Jing, Qin Xiaosong, Liu Yong, Wang Qingtao, Li Yongzhe, Qin Dongch |
| HLA polymorphism and risk of multiple myeloma. Leukemia 2016 Jul . Beksac M, Gragert L, Fingerson S, Maiers M, Zhang M-J, Albrecht M, Zhong X, Cozen W, Dispenzieri A, Lonial S, Hari |
| KIR genotype distribution among patients with multiple myeloma: Higher prevalence of KIR 2DS4 and KIR 2DS5 genes. Meta gene 2014 Dec 2 730-6. Hoteit R, Bazarbachi A, Antar A, Salem Z, Shammaa D, Mahfouz |
| The Association of HLA Class 1 and Class 2 Antigens with Multiple Myeloma in Iranian Patients. Turkish journal of haematology : official journal of Turkish Society of Haematology 2014 Dec 31 (4): 388-393. Sayad Arezou, Akbari Mohammad Taghi, Mehdizadeh Mahshid, Roshandel Elham, Abedinpour Soheila, Hajifathali Abb |
| Major histocompatibility complex class II polymorphisms are associated with the development of anti-resorptive agent-induced osteonecrosis of the jaw. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 2013 Jan 41 (1): 71-5. Stockmann Philipp, Nkenke Emeka, Englbrecht Matthias, Schlittenbauer Tilo, Wehrhan Falk, Rauh Claudia, Beckmann Matthias W, Fasching Peter A, Kreusch Thomas, Mackensen Andreas, Wullich Bernd, Schett Georg, Spriewald Bernd |
| The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease. Tissue antigens 2008 Jun 71 (6): 548-51. Alcoceba M, Marín L, Balanzategui A, Sarasquete M E, Martín-Jiménez P, Chillón M C, Corral R, Pérez-Persona E, Fernández-Calvo F J, Hernández J M, Bladé J, Lahuerta J J, González M, San Miguel J F, García-Sanz |
- Page last reviewed:Jul 25, 2022
- Page last updated:Sep 27, 2022
- Content source: